Join Zoom Meeting
https://mc-meet.zoom.us/j/95869608121?pwd=NG9GaG5JWE44eGpSckdRWHFSNnVkUT09
 
Meeting ID: 958 6960 8121
Passcode: 636276

Visiting Faculty
David Wolk, M.D.
"Grappling with AD co-Pathologies in the Therapeutic Era"

Dr. Wolk has the following relevant financial relationships to disclose: Consulting: Eli Lilly; Beckman Coulter; GSK (DSMB); and Grant/Research: Biogen (paid to my institution) and does not intend to discuss any off-label/investigative use of Pharmaceuticals or Instruments. 

Learning Objectives:
Upon conclusion of this activity, participants will be able to:

•    Describe the association of co-pathologies with AD and their role in AD heterogeneity
•    Summarize the probabilistic link between neurodegenerative measures and different pathologies
•    Describe strategies for disentangling AD related versus non-AD related  factors contributing to neurodegeneration and cognitive decline.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.